K042735

Substantially Equivalent

N ANTISERA TO HUMAN IMMUNOGLOBULINS (IGG, IGA AND IGM)

Applicant: Dade Behring, Inc.
Product code: CFN
Advisory panel: Immunology
Date received: 2004-10-01
Decision date: 2005-02-15
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Newark, DE, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.